World
Monod Bio Unveils LuxSit™ Pro: World's First Commercial De Novo Luciferases for Research and Diagnostics
Monod Bio, a life sciences company using AI to generate new proteins for the research use only (RUO) and in vitro diagnostics (IVD) markets, announce...
July 16, 2024 | News
Thermo Fisher Completes $3.1 Billion Acquisition of Olink Holding AB
Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, announced that it has completed its acquisiti...
July 11, 2024 | News
Eppendorf Award for Young European Investigators 2024 goes to Clemens Plaschka, Austria
Clemens Plaschka, born 1989, receives the 20,000 euro award for his research on the molecular machines that generate and export messenger&nbs...
July 04, 2024 | News
HiRO Acquires DeltaMed Solutions, Expands Across 10 Countries
Harvest Integrated Research Organization (HiRO), a full-service, boutique global CRO, is excited to announce its latest strategic move with the successful ...
July 02, 2024 | News
Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
Renowned, experienced industry leader in newly created role for Cytiva Ruffieux joins Cytiva executive team on 1 July 2024 Cytiva is strength...
June 28, 2024 | News
Ochre Bio and GSK Enter Multi-Year Partnership to Advance Liver Disease Research
Ochre Bio, a pioneer in chronic liver disease medicine development, has today announced the start of a multi-year data licence agreement with GSK. The part...
June 13, 2024 | News
Philips Survey Reveals Strong Public Support for Sustainable Healthcare in Asia Pacific
Royal Philips , a global leader in health technology, announced findings from its Sustainable Healthcare survey in Asia Pacific (APAC)...
June 06, 2024 | News
Fortrea Launches Comprehensive Solution to Enhance Diversity and Inclusion in Clinical Trials
Fortrea, a leading global contract research organization (CRO), today announced its comprehensive and integrated solution to improve the diversity an...
May 31, 2024 | News
Thermo Fisher's Mission: A Healthier, Cleaner, and Safer World, says CEO Marc N. Casper
Report highlights company’s commitments to all of its stakeholders and society Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in servin...
May 28, 2024 | Opinion
Aptamer Group Signs £465,000 Agreement for Development of Cervical Cancer Blood Test
Agreement for up to £465,000 signed for Optimer development Optimer binders will be developed for use in a cervical cance...
May 22, 2024 | News
CEO Matt Foehr Announces OmniAb's Strong Start in 2024 with New Partnerships and Expanded Portfolio
OmniAb, reported financial results for the three months ended March 31, 2024, and provided operating and partner program updates. “The OmniAb t...
May 10, 2024 | Company results
Latus Bio Launches with $54 Million Series A to Advance CNS Gene Therapy
Latus Bio, a biotechnology company developing novel gene therapy candidates for disorders of the central nervous system (CNS), today announced its launch a...
May 03, 2024 | News
ImmunityBio and Serum Institute of India Secure Global BCG Supply Agreement for Cancer Treatment
Collaboration will result in BCG manufacture at large scale for use in combination with ANKTIVA®, ImmunityBio’s recently approved treatme...
May 03, 2024 | News
Alnylam and Medison Expand Global Partnership to Accelerate Access to Innovative Therapies
The expanded partnership will allow Alnylam and Medison to help accelerate access for patients in multiple regions under one glo...
May 01, 2024 | News
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
Editor Picks
